Evidence map›Paper›PMID 37872196›Full record

ArticleNPJ Regenerative medicine2023

Local decorin delivery via hyaluronic acid microrods improves cardiac performance, ventricular remodeling after myocardial infarction.

Priya Mohindra, Justin X Zhong, Qizhi Fang, Darnell L Cuylear, Cindy Huynh, Huiliang Qiu, Dongwei Gao, Bhushan N Kharbikar, Xiao Huang, Matthew L Springer and 2 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Regenerative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Priya MohindraUC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-1404-8016
Justin X ZhongUC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-5249-8515
Qizhi FangDivision of Cardiology, University of California, San Francisco, San Francisco, CA, USA.
Darnell L CuylearDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-8120-4501
Cindy HuynhDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Huiliang QiuDivision of Cardiology, University of California, San Francisco, San Francisco, CA, USA.
Dongwei GaoDivision of Cardiology, University of California, San Francisco, San Francisco, CA, USA.
Bhushan N KharbikarDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-0394-0308
Xiao HuangDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Matthew L SpringerDivision of Cardiology, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6689-8234
Randall J LeeUC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA.
Tejal A DesaiUC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA. Tejal_Desai@brown.edu.ORCID http://orcid.org/0000-0003-3409-9208
University of California, San Francisco · USBrigham and Women's Hospital · US

Funding

UCSF/UCB Joint Graduate Group in BIoengineeringT32GM008155 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DESAI, TEJAL A. · 1985 to 2020
$12.2M
Microstructural Cues for the Treatment of Heart FailureR01HL137209 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DESAI, TEJAL A. · 2018 to 2021
$1.6M
NHLBI NIH HHS R01 HL137209NIGMS NIH HHS T32 GM008155
6 · The paper itself

Abstract

Heart failure (HF) remains a global public health burden and often results following myocardial infarction (MI). Following injury, cardiac fibrosis forms in the myocardium which greatly hinders cellular function, survival, and recruitment, thus severely limits tissue regeneration. Here, we leverage biophysical microstructural cues made of hyaluronic acid (HA) loaded with the anti-fibrotic proteoglycan decorin to more robustly attenuate cardiac fibrosis after acute myocardial injury. Microrods showed decorin incorporation throughout the entirety of the hydrogel structures and exhibited first-order release kinetics in vitro. Intramyocardial injections of saline (n = 5), microrods (n = 7), decorin microrods (n = 10), and free decorin (n = 4) were performed in male rat models of ischemia-reperfusion MI to evaluate therapeutic effects on cardiac remodeling and function. Echocardiographic analysis demonstrated that rats treated with decorin microrods (5.21% ± 4.29%) exhibited significantly increased change in ejection fraction (EF) at 8 weeks post-MI compared to rats treated with saline (-4.18% ± 2.78%, p < 0.001) and free decorin (-3.42% ± 1.86%, p < 0.01). Trends in reduced end diastolic volume were also identified in decorin microrod-treated groups compared to those treated with saline, microrods, and free decorin, indicating favorable ventricular remodeling. Quantitative analysis of histology and immunofluorescence staining showed that treatment with decorin microrods reduced cardiac fibrosis (p < 0.05) and cardiomyocyte hypertrophy (p < 0.05) at 8 weeks post-MI compared to saline control. Together, this work aims to contribute important knowledge to guide rationally designed biomaterial development that may be used to successfully treat cardiovascular diseases.

Identifiers

PMID37872196
PMCPMC10593781
OpenAlexW4387871868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.